[1]
Shiny George et al. 2021. Molecular Docking and Pharmacokinetic Prediction Studies of Novel Coumarin Derivatives as Arylamine N- acetyltransferase 2 Inhibitors. Current Aspects in Pharmaceutical Research and Development Vol. 2. (Sep. 2021), 61–68. DOI:https://doi.org/10.9734/bpi/caprd/v2/12583D.